Tadalafil
- Product NDC
- 71610-213
- 11-digit product format
- 716100213
- Labeler code
- 71610
- Product ID
- 71610-213_004c75b3-29f0-4e32-82fe-fec4ce0350d3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tadalafil
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- NDA021368
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2018-09-27
- Marketing end
- 0000-00-00
- Substance
- TADALAFIL
- Active strength
- 20 mg/1
- Pharmacologic classes
- Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71610-213 | TADALAFIL TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | Legacy NDC | 20190110_1621128d-56e9-48f0-876c-77081daa7f12.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71610-213-04 | 71610021304 | 4 TABLET, FILM COATED in 1 BOTTLE (71610-213-04) | 2018-12-28 | 0000-00-00 | No | No | Current |
| 71610-213-12 | 71610021312 | 12 TABLET, FILM COATED in 1 BOTTLE (71610-213-12) | 2018-12-28 | 0000-00-00 | No | No | Current |